110 results
424B3
SLNO
Soleno Therapeutics Inc
14 Oct 15
Prospectus supplement
12:00am
of claims, then each employee will be entitled to the following severance payments and benefits:
Dr. Bhatnagar
if such termination or resignation … that the severance benefits provided for in the Employment Agreement or otherwise payable to each employee (i) constitute “parachute payments” within
8-K
EX-10.1
SLNO
Soleno Therapeutics Inc
13 Nov 20
Termination of a Material Definitive Agreement
4:02pm
employment with the Company. However, as described in this Agreement, Executive may be entitled to severance benefits depending on the circumstances … at least thirty (30) days prior to the date of automatic renewal. If Executive becomes entitled to benefits under Section 8 during the term
8-K
EX-10.3
SLNO
Soleno Therapeutics Inc
13 Jan 21
Departure of Directors or Certain Officers
4:05pm
payable through the date of termination of employment and any other employee benefits earned and owed through the date of termination, the following … benefits from the Company:
(i) continuing payments of severance pay in accordance with the Company’s normal payroll policies at a rate equal to Executive’s
8-K
EX-99.1
SLNO
Soleno Therapeutics Inc
15 Apr 21
Other Events
12:00am
6 to 10 months, during which the FDA evaluates all data to ensure that any drug they approve is safe and effective, and that the benefits outweigh … pandemic. It is this totality of evidence that we believe provides information on the potential risks and benefits of DCCR in PWS.
Prior to submitting
8-K/A
EX-99.1
hv1c ksz4n
10 Apr 17
Other Events
12:00am
424B3
otqhmcvbba
12 Apr 19
Prospectus supplement
4:41pm
8-K
EX-1.2
d5jojgc7k
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
S-1/A
EX-10.5
phbe7rafv2 pw5w013r1
1 Jul 14
IPO registration (amended)
12:00am